ARCHIVES

NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups.

This article is from The Cancer Letter archive.

Vol. 33 No. 01 | January 12, 2007

Download PDF Visit The Full Archive

Related Articles

NIH, NCI Being Discussions With HCFA On Reimbursement

April 26, 1996

Stand Up To Cancer Says $80 Million in Pledges Raised

September 17, 2010

Also Anna Barker gets new, longer title at NCI; Mark Clanton named deputy director for care, delivery.

February 13, 2004

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

Existing HER2 Drugs May Help More In Breast Cancer Treatment

January 25, 2013

Navelbine+Herceptin: 78% Response In Breast Cancer

November 29, 2002